SEARCH

SEARCH BY CITATION

References

  • 1
    Akeson EC, Lambert JP, Narayanswami S, Gardiner K, Bechtel LJ, Davisson MT (2001) Ts65Dn—localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndrome. Cytogenet Cell Genet 93:270276.
  • 2
    Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA (2005) Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry 62:685691.
  • 3
    Bierer LM, Haroutunian V, Gabriel S, Knott PJ, Carlin LS, Purohit DP et al (1995) Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem 64:749760.
  • 4
    Campbell WA, Lowther J, McKenzie I, Price WH (1982) Serum gonadotrophins in Down's syndrome. J Med Genet 19:9899.
  • 5
    Carothers AD, Hecht CA, Hook EB (1999) International variation in reported livebirth prevalence rates of Down syndrome, adjusted for maternal age. J Med Genet 36:386393.
  • 6
    Casanova MF, Walker LC, Whitehouse PJ, Price DL (1985) Abnormalities of the nucleus basalis in Down's syndrome. Ann Neurol 18:310313.
  • 7
    Chang Q, Gold PE (2008) Age-related changes in memory and in acetylcholine functions in the hippocampus in the Ts65Dn mouse, a model of Down syndrome. Neurobiol Learn Mem 89:167177.
  • 8
    Chapman RS, Hesketh LJ (2000) Behavioral phenotype of individuals with Down syndrome. Ment Retard Dev Disabil Res Rev 6:8495.
  • 9
    Cheng RK, MacDonald CJ, Williams CL, Meck WH (2008) Prenatal choline supplementation alters the timing, emotion, and memory performance (TEMP) of adult male and female rats as indexed by differential reinforcement of low-rate schedule behavior. Learn Mem 15:153162.
  • 10
    Chrast R, Scott HS, Papasavvas MP, Rossier C, Antonarakis ES, Barras C et al (2000) The mouse brain transcriptome by SAGE: differences in gene expression between P30 brains of the partial trisomy 16 mouse model of Down syndrome (Ts65Dn) and normals. Genome Res 10:20062021.
  • 11
    Chu Y, Cochran EJ, Bennett DA, Mufson EJ, Kordower JH (2001) Down-regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease. J Comp Neurol 437:296307.
  • 12
    Contestabile A, Fila T, Bartesaghi R, Contestabile A, Ciani E (2006) Choline acetyltransferase activity at different ages in brain of Ts65Dn mice, an animal model for Down's syndrome and related neurodegenerative diseases. J Neurochem 97:515526.
  • 13
    Contestabile A, Ciani E, Contestabile A (2008) The place of choline acetyltransferase activity measurement in the “cholinergic hypothesis” of neurodegenerative diseases. Neurochem Res 33:318327.
  • 14
    Cooper JD, Salehi A, Delcroix JD, Howe CL, Belichenko PV, Chua-Couzens J et al (2001) Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Proc Natl Acad Sci U S A 98:1043910444.
  • 15
    Cosgrove KP, Mazure CM, Staley JK (2007) Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry 62:847855.
  • 16
    Counts SE, Mufson EJ (2005) The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease. J Neuropathol Exp Neurol 64:263272.
  • 17
    Counts SE, Che S, Ginsberg SD, Mufson EJ (2011) Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease. J Chem Neuroanat 42:111117.
  • 18
    Cowell PE, Turetsky BI, Gur RC, Grossman RI, Shtasel DL, Gur RE (1994) Sex differences in aging of the human frontal and temporal lobes. J Neurosci 14:47484755.
  • 19
    Coyle JT, Oster-Granite ML, Gearhart JD (1986) The neurobiologic consequences of Down syndrome. Brain Res Bull 16:773787.
  • 20
    Cuello AC, Bruno MA, Bell KF (2007) NGF-cholinergic dependency in brain aging, MCI and Alzheimer's disease. Curr Alzheimer Res 4:351358.
  • 21
    Davies P, Maloney AJ (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2:1403.
  • 22
    Davisson MT, Schmidt C, Akeson EC (1990) Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome. Prog Clin Biol Res 360:263280.
  • 23
    Davisson MT, Schmidt C, Reeves RH, Irving NG, Akeson EC, Harris BS, Bronson RT (1993) Segmental trisomy as a mouse model for Down syndrome. Prog Clin Biol Res 384:117133.
  • 24
    Delcroix JD, Valletta J, Wu C, Howe CL, Lai CF, Cooper JD et al (2004) Trafficking the NGF signal: implications for normal and degenerating neurons. Prog Brain Res 146:323.
  • 25
    Downes EC, Robson J, Grailly E, Abdel-All Z, Xuereb J, Brayne C et al (2008) Loss of synaptophysin and synaptosomal-associated protein 25-kDa (SNAP-25) in elderly Down syndrome individuals. Neuropathol Appl Neurobiol 34:1222.
  • 26
    Epstein CJ (1986) Developmental genetics. Experientia 42:11171128.
  • 27
    Faizi M, Bader PL, Tun C, Encarnacion A, Klechevnikov A, Belichenko P et al (2011) Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer. Neurobiol Dis 43:397413.
  • 28
    Fleisher A, Grundman M, Jack CR Jr, Petersen RC, Taylor C, Kim HT et al; Alzheimer's Disease Cooperative Study (2005) Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol 62:953957.
  • 29
    Galea LA, Ormerod BK, Sampath S, Kostaras X, Wilkie DM, Phelps MT (2000) Spatial working memory and hippocampal size across pregnancy in rats. Horm Behav 37:8695.
  • 30
    Ginsberg SD, Price DL, Blackstone CD, Huganir RL, Martin LJ (1995) Non-NMDA glutamate receptors are present throughout the primate hypothalamus. J Comp Neurol 353:539552.
  • 31
    Glasson EJ, Sullivan SG, Hussain R, Petterson BA, Montgomery PD, Bittles AH (2002) The changing survival profile of people with Down's syndrome: implications for genetic counselling. Clin Genet 62:390393.
  • 32
    González-Agüero A, Ara I, Moreno LA, Vicente-Rodríguez G, Casajús JA (2011) Fat and lean masses in youths with Down syndrome: gender differences. Res Dev Disabil 32:16851693.
  • 33
    Granholm AC, Sanders LA, Crnic LS (2000) Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome. Exp Neurol 161:647663.
  • 34
    Granholm AC, Ford KA, Hyde LA, Bimonte HA, Hunter CL, Nelson M et al (2002) Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome. Physiol Behav 77:371385.
  • 35
    Granholm AC, Sanders L, Seo H, Lin L, Ford K, Isacson O (2003) Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndrome. Hippocampus 13:905914.
  • 36
    Gsell W, Jungkunz G, Riederer P (2004) Functional neurochemistry of Alzheimer's disease. Curr Pharm Des 10:265293.
  • 37
    Gundersen HJ (1988) The nucleator. J Microsc 151:321.
  • 38
    Gundersen HJ, Jensen EB, Kiêu K, Nielsen J (1999) The efficiency of systematic sampling in stereology—reconsidered. J Microsc 193:199211.
  • 39
    Hassold TJ, Jacobs PA (1984) Trisomy in man. Annu Rev Genet 18:6997.
  • 40
    Haug H, Knebel G, Mecke E, Orün C, Sass NL (1981) The aging of cortical cytoarchitectonics in the light of stereological investigations. Prog Clin Biol Res 59B:193197.
  • 41
    Haug H, Kühl S, Mecke E, Sass NL, Wasner K (1984) The significance of morphometric procedures in the investigation of age changes in cytoarchitectonic structures of human brain. J Hirnforsch 25:353374.
  • 42
    Hayes A, Batshaw ML (1993) Down syndrome. Pediatr Clin North Am 40:523535.
  • 43
    Hestnes A, Stovner LJ, Husøy O, Følling I, Fougner KJ, Sjaastad O (1991) Hormonal and biochemical disturbances in Down's syndrome. J Ment Defic Res 35:179193.
  • 44
    Ho KC, Roessmann U, Straumfjord JV, Monroe G (1980) Analysis of brain weight. II. Adult brain weight in relation to body height, weight, and surface area. Arch Pathol Lab Med 104:640645.
  • 45
    Holtzman DM, Santucci D, Kilbridge J, Chua-Couzens J, Fontana DJ, Daniels SE et al (1996) Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc Natl Acad Sci U S A 93:1333313338.
  • 46
    Hsiang YH, Berkovitz GD, Bland GL, Migeon CJ, Warren AC (1987) Gonadal function in patients with Down syndrome. Am J Med Genet 27:449458.
  • 47
    Hunter CL, Isacson O, Nelson M, Bimonte-Nelson H, Seo H, Lin L et al (2003) Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome. Neurosci Res 45:437445.
  • 48
    Hunter CL, Bachman D, Granholm AC (2004) Minocycline prevents cholinergic loss in a mouse model of Down's syndrome. Ann Neurol 56:675688.
  • 49
    Hunter CL, Bimonte-Nelson HA, Nelson M, Eckman CB, Granholm AC (2004) Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen. Neurobiol Aging 25:873884.
  • 50
    Janicki MP, Dalton AJ, Henderson CM, Davidson PW (1999) Mortality and morbidity among older adults with intellectual disability: health services considerations. Disabil Rehabil 21:284294.
  • 51
    Keenan PA, Ezzat WH, Ginsburg K, Moore GJ (2001) Prefrontal cortex as the site of estrogen's effect on cognition. Psychoneuroendocrinology 26:577590.
  • 52
    Kelley CM, Perez SE, Overk CR, Wynick D, Mufson EJ (2011) Effect of neocortical and hippocampal amyloid deposition upon galaninergic and cholinergic neurites in AβPPswe/PS1ΔE9 mice. J Alzheimers Dis 25:491504.
  • 53
    Klintsova A, Levy WB, Desmond NL (1995) Astrocytic volume fluctuates in the hippocampal CA1 region across the estrous cycle. Brain Res 690:269274.
  • 54
    Koylu E, Demirgören S, London ED, Pöğün S (1997) Sex difference in up-regulation of nicotinic acetylcholine receptors in rat brain. Life Sci 61:PL 185PL 190.
  • 55
    Lai F, Williams RS (1989) A prospective study of Alzheimer disease in Down syndrome. Arch Neurol 46:849853.
  • 56
    LeMay M, Alvarez N (1990) The relationship between enlargement of the temporal horns of the lateral ventricles and dementia in aging patients with Down syndrome. Neuroradiology 32:104107.
  • 57
    Lockrow J, Prakasam A, Huang P, Bimonte-Nelson H, Sambamurti K, Granholm AC (2009) Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model. Exp Neurol 216:278289.
  • 58
    Lockrow J, Boger H, Bimonte-Nelson H, Granholm AC (2011) Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome. Behav Brain Res 221:610622.
  • 59
    Loy R, Sheldon RA (1987) Sexually dimorphic development of cholinergic enzymes in the rat septohippocampal system. Brain Res 431:156160.
  • 60
    Lubec G, Engidawork E (2002) The brain in Down syndrome (TRISOMY 21). J Neurol 249:13471356.
  • 61
    Määttä T, Tervo-Määttä T, Taanila A, Kaski M, Iivanainen M (2006) Mental health, behaviour and intellectual abilities of people with Down syndrome. Downs Syndr Res Pract 11:3743.
  • 62
    Madeira MD, Lieberman AR (1995) Sexual dimorphism in the mammalian limbic system. Prog Neurobiol 45:275333.
  • 63
    Mann DM, Yates PO, Marcyniuk B (1984) Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer's disease and their relationship to ageing and to the accumulation of lipofuscin pigment. Mech Ageing Dev 25:189204.
  • 64
    Margallo-Lana M, Morris CM, Gibson AM, Tan AL, Kay DW, Tyrer SP et al (2004) Influence of the amyloid precursor protein locus on dementia in Down syndrome. Neurology 62:19961998.
  • 65
    Martínez-Cué C, Baamonde C, Lumbreras M, Paz J, Davisson MT, Schmidt C et al (2002) Differential effects of environmental enrichment on behavior and learning of male and female Ts65Dn mice, a model for Down syndrome. Behav Brain Res 134:185200.
  • 66
    Martínez-Cué C, Rueda N, García E, Flórez J (2006) Anxiety and panic responses to a predator in male and female Ts65Dn mice, a model for Down syndrome. Genes Brain Behav 5:413422.
  • 67
    McEwen BS, Alves SE, Bulloch K, Weiland NG (1998) Clinically relevant basic science studies of gender differences and sex hormone effects. Psychopharmacol Bull 34:251259.
  • 68
    McGeer PL, McGeer EG, Suzuki J, Dolman CE, Nagai T (1984) Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain. Neurology 34:741745.
  • 69
    Menéndez M (2005) Down syndrome, Alzheimer's disease and seizures. Brain Dev 27:246252.
  • 70
    Mesulam MM, Mufson EJ, Levey AI, Wainer BH (1983) Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol 214:170197.
  • 71
    Mufson EJ, Bothwell M, Kordower JH (1989) Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across subregions of the basal forebrain. Exp Neurol 105:221232.
  • 72
    Mufson EJ, Ma SY, Cochran EJ, Bennett DA, Beckett LA, Jaffar S et al (2000) Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol 427:1930.
  • 73
    Mufson EJ, Ma SY, Dills J, Cochran EJ, Leurgans S, Wuu J et al (2002) Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol 443:136153.
  • 74
    Mufson EJ, Counts SE, Fahnestock M, Ginsberg SD (2007) Cholinotrophic molecular substrates of mild cognitive impairment in the elderly. Curr Alzheimer Res 4:340350.
  • 75
    Munro CA, McCaul ME, Wong DF, Oswald LM, Zhou Y, Brasic J et al (2006) Sex differences in striatal dopamine release in healthy adults. Biol Psychiatry 59:966974.
  • 76
    Murthy SK, Malhotra AK, Mani S, Shara ME, Al-Rowaished EE, Naveed S et al (2007) Incidence of Down syndrome in Dubai, UAE. Med Princ Pract 16:2528.
  • 77
    Nagumo N (1994) The nature of intelligence in adults with Down syndrome: IQ distribution and sex differences. Shinrigaku Kenkyu 65:240245.
  • 78
    Nordberg A, Lilja A, Lundqvist H, Hartvig P, Amberla K, Viitanen M et al (1992) Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography. Neurobiol Aging 13:747758.
  • 79
    Overk CR, Kelley CM, Mufson EJ (2009) Brainstem Alzheimer's-like pathology in the triple transgenic mouse model of Alzheimer's disease. Neurobiol Dis 35:415425.
  • 80
    Pakkenberg B, Gundersen HJ (1997) Neocortical neuron number in humans: effect of sex and age. J Comp Neurol 384:312320.
  • 81
    Perry EK, Perry RH, Gibson PH, Blessed G, Tomlinson BE (1977) A cholinergic connection between normal aging and senile dementia in the human hippocampus. Neurosci Lett 6:8589.
  • 82
    Prasher VP, Farrer MJ, Kessling AM, Fisher EM, West RJ, Barber PC, Butler AC (1998) Molecular mapping of Alzheimer-type dementia in Down's syndrome. Ann Neurol 43:380383.
  • 83
    Rabinowicz T, Petetot JM, Gartside PS, Sheyn D, Sheyn T, de Courten-Myers GM (2002) Structure of the cerebral cortex in men and women. J Neuropathol Exp Neurol 61:4657.
  • 84
    Reeves RH, Irving NG, Moran TH, Wohn A, Kitt C, Sisodia SS et al (1995) A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet 11:177184.
  • 85
    Roizen NJ, Patterson D (2003) Down's syndrome. Lancet 361:12811289.
  • 86
    Roth GM, Sun B, Greensite FS, Lott IT, Dietrich RB (1996) Premature aging in persons with Down syndrome: MR findings. Am J Neuroradiol 17:12831289.
  • 87
    Rye DB, Wainer BH, Mesulam MM, Mufson EJ, Saper CB (1984) Cortical projections arising from the basal forebrain: a study of cholinergic and noncholinergic components employing combined retrograde tracing and immunohistochemical localization of choline acetyltransferase. Neuroscience 13:627643.
  • 88
    Salehi A, Delcroix JD, Belichenko PV, Zhan K, Wu C, Valletta JS et al (2006) Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron 51:2942.
  • 89
    Schupf N, Zigman W, Kapell D, Lee JH, Kline J, Levin B (1997) Early menopause in women with Down's syndrome. J Intellect Disabil Res 41:264267.
  • 90
    Schupf N, Winsten S, Patel B, Pang D, Ferin M, Zigman WB et al (2006) Bioavailable estradiol and age at onset of Alzheimer's disease in postmenopausal women with Down syndrome. Neurosci Lett 406:298302.
  • 91
    Sendera TJ, Ma SY, Jaffar S, Kozlowski PB, Kordower JH, Mawal Y et al (2000) Reduction in TrkA-immunoreactive neurons is not associated with an overexpression of galaninergic fibers within the nucleus basalis in Down's syndrome. J Neurochem 74:11851196.
    Direct Link:
  • 92
    Seo H, Isacson O (2005) Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model mice. Exp Neurol 193:469480.
  • 93
    Sherman SL, Allen EG, Bean LH, Freeman SB (2007) Epidemiology of Down syndrome. Ment Retard Dev Disabil Res Rev 13:221227.
  • 94
    Stewart LS, Persinger MA, Cortez MA, Snead OC 3rd (2007) Chronobiometry of behavioral activity in the Ts65Dn model of Down syndrome. Behav Genet 37:388398.
  • 95
    Thase ME, Liss L, Smeltzer D, Maloon J (1982) Clinical evaluation of dementia in Down's syndrome: a preliminary report. J Ment Defic Res 26:239244.
  • 96
    Whitehouse PJ, Struble RG, Hedreen JC, Clark AW, White CL, Parhad IM, Price DL (1983) Neuroanatomical evidence for a cholinergic deficit in Alzheimer's disease. Psychopharmacol Bull 19:437440.
  • 97
    Wilcock GK, Esiri MM, Bowen DM, Smith CC (1982) Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci 57:407417.
  • 98
    Yates CM, Simpson J, Maloney AF, Gordon A, Reid AH (1980) Alzheimer-like cholinergic deficiency in Down syndrome. Lancet 2:979.
  • 99
    Yates CM, Simpson J, Gordon A, Maloney AF, Allison Y, Ritchie IM, Urquhart A (1983) Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome. Brain Res 280:119126.
  • 100
    Zhou JN, Hofman MA, Swaab DF (1995) VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease. Neurobiol Aging 16:571576.
  • 101
    Zimmerman ME, Lipton RB, Santoro N, McConnell DS, Derby CA, Katz MJ et al (2011) Endogenous estradiol is associated with verbal memory in nondemented older men. Brain Cogn 76:158165.